Antipodes to acquire Maple-Brown Abbott.

Antipodes, a team that specializes in global shares investing, agreed to acquire Maple-Brown Abbott, an investment management firm. Financial terms were not disclosed. The acquisition will see the expanded Antipodes Group oversee a combined AUD18.6bn in assets, approximately 30% of which is sourced from offshore clients.